share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA

SEC ·  Jul 13 04:19

Summary by Futu AI

Brenda Cooperstone, a reporting person associated with Senti Biosciences, Inc. (SNTI.US), has been involved in a transaction with the company's stock. The action took place on July 10, 2024. However, the specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed in the provided announcement.
Brenda Cooperstone, a reporting person associated with Senti Biosciences, Inc. (SNTI.US), has been involved in a transaction with the company's stock. The action took place on July 10, 2024. However, the specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed in the provided announcement.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.